Why hormone therapy stops working after CDK4/6 — and what we do instead | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer whose cancer […]
Lifting the Tail: How Immunotherapy Changed Long-Term Survival in Advanced Cancer | Dr Dilanka De Silva
Who this is for: People diagnosed with advanced cancer — including melanoma, lung cancer, kidney cancer, or bile duct cancer
Early breast cancer in Melbourne: how treatment decisions are made today | Dr Dilanka De Silva
Who this is for This page is for people who have recently been diagnosed with early-stage breast cancer — cancer
Advanced bile duct cancer (cholangiocarcinoma): how immunotherapy changed survival (TOPAZ-1) | Dr Dilanka De Silva
Who this is for: People with advanced bile duct cancer (cholangiocarcinoma, gallbladder cancer, or other biliary tract cancers) who want
TAILORx: when chemotherapy can safely be avoided in early breast cancer | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative early breast cancer who have been told
RxPONDER: when chemotherapy can be avoided in some node-positive breast cancers | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative early breast cancer that has spread to
Why lymph node–positive breast cancer is not all the same | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative early breast cancer who have been told
Advanced breast cancer treatment in Melbourne: what happens after CDK4/6 inhibitors stop working | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer whose cancer
Why hormone therapy stops working after CDK4/6 — and what we do instead | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer whose cancer
Why one breast cancer drug replaced the old standard almost overnight (DESTINY-Breast03) | Dr Dilanka De Silva
Who this is for This page is for people with HER2-positive metastatic breast cancer who have previously received trastuzumab and